Developed by the Elizabeth Glaser Pediatric AIDS Foundation and Unitaid, this guidance recommends key steps and considerations for quantification of WHO-recommended first- and second-line optimal pediatric ARVs.
top of page
A framework to support new product introduction in national health systems
bottom of page
Comments